Correction: Real-World Evidence on the Clinical Efficacy of Long-Acting Injectable Antipsychotics for Schizophrenia Spectrum Disorders - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Real-World Evidence on the Clinical Efficacy of Long-Acting Injectable Antipsychotics for Schizophrenia Spectrum Disorders

  • By

  • Elif Merve Kurt Tunagur

  • Mustafa Tolga Tunagur

  • April 17, 2026

Share

  • 1

    The article discusses a correction regarding the p-value in a study on long-acting injectable antipsychotics.

  • 2

    The original p-value reported was <0.17, which has been corrected to <0.017.

  • 3

    This correction impacts the statistical analysis presented in the original article.

  • 4

    The correction was published in BMC Psychiatry, volume 26, article 143.

  • 5

    The authors have acknowledged and rectified the error in the published study.

Original Source(s)

Related Content